WallStreetZenWallStreetZen

NASDAQ: FNCH
Finch Therapeutics Group Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

FNCH past revenue growth

How has FNCH's revenue growth performed historically?
Company
-96%
Industry
69.54%
Market
14.01%
FNCH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FNCH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

FNCH earnings and revenue history

Current Revenue
$614.0k
Current Earnings
-$154.0M
Current Profit Margin
-25,084.4%

FNCH Return on Equity

Current Company
-150.8%
Current Industry
-18%
Current Market
30.8%
FNCH's Return on Equity (-150.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when FNCH announces earnings.

FNCH Return on Assets

Current Company
-93.6%
Current Industry
0.9%
FNCH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FNCH Return on Capital Employed

Current Company
-240.21%
Current Industry
14.1%

FNCH vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FNCH$614.00k-$152.60M-$154.02M-74.55%N/A
INDP$0.00-$15.21M-$15.21MN/AN/A
EVLO$0.00-$99.17M-$110.01MN/AN/A
NNVC$0.00-$6.05M-$6.80MN/AN/A
ACGN$0.00-$29.87M-$23.36M-100.00%N/A
View Top Biotech Stocks

Finch Therapeutics Group Earnings & Revenue FAQ

What were FNCH's earnings last quarter?

On Invalid Date, Finch Therapeutics Group (NASDAQ: FNCH) reported Q1 2023 earnings per share (EPS) of -$1.33, up 155.77% year over year. Total Finch Therapeutics Group earnings for the quarter were -$63.94 million. In the same quarter last year, Finch Therapeutics Group's earnings per share (EPS) was -$0.52.

If you're new to stock investing, here's how to buy Finch Therapeutics Group stock.

What was FNCH's earnings growth in the past year?

As of Q2 2023, Finch Therapeutics Group's earnings has grown year over year. Finch Therapeutics Group's earnings in the past year totalled -$154.02 million.

What was FNCH's revenue last quarter?

On Invalid Date, Finch Therapeutics Group (NASDAQ: FNCH) reported Q1 2023 revenue of $107.00 thousand up 69.77% year over year. In the same quarter last year, Finch Therapeutics Group's revenue was $354.00 thousand.

What was FNCH's revenue growth in the past year?

As of Q2 2023, Finch Therapeutics Group's revenue has grown -96% year over year. This is 165.53 percentage points lower than the US Biotechnology industry revenue growth rate of 69.54%. Finch Therapeutics Group's revenue in the past year totalled $614.00 thousand.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.